Abstract Details

Title Contribution of a dysfunctional RNA binding protein, hnRNP A1, to neurodegeneration in MS

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 003

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Michael C. Levin, MD, FAAN (University of Saskatchewan) PRESENTER	Dr. Levin has received personal compensation for serving as an employee of Merck. Dr. Levin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Levin has received research support from CIHR.
	No disclosure on file
Lidia Gardner, PhD, EMBA (Novartis Pharmaceutical Corporation)	Dr. Gardner has stock in EMD Serono.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Benjamin M. Segal, MD (University of Michigan)	Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bloom, Inc. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. The institution of Dr. Segal has received research support from NIH. Dr. Segal has received intellectual property interests from a discovery or technology relating to health care. Dr. Segal has received intellectual property interests from a discovery or technology relating to health care. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Expert talks moderator; writer/ commentator with Ology Medical Education, Inc/ Neurodiem.
Sarah Gheuens, MD	No disclosure on file